Neoplasm history increases morbidity and mortality after solid organ transplantation and has disqualified patients from transplantation. Studies are needed to identify factors to be considered when deciding on the suitability of a patient with previous tumor for heart transplantation. A retrospective epidemiological study was conducted in heart transplant (HT) recipients (Spanish Post-Heart Transplant Tumor Registry) comparing the epidemiological data, immu-nosuppressive treatments and incidence of post-HT tumors between patients with previous malignant noncardiac tumor and with no previous tumor (NPT). The impact of previous tumor (PT) on overall survival (OS) was also assessed. A total of 4561 patients, 77 PT and 4484 NPT, were evaluated....
Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by ...
Background. Malignancy is the leading cause of death in Taiwan. The risk of malignancy is higher in ...
To assess the long-term risk of developing cancer among heart transplant recipients compared to the ...
[Abstract] Neoplasm history increases morbidity and mortality after solid organ transplantation and ...
The risk of cancer in heart transplant recipients. Association between heart transplantation and the...
The prevalence of different cancers after heart transplant (HT) is unclear due to small and conflict...
BackgroundThe purpose of this study was to assess the incidence and type of malignancies after heart...
OBJECTIVES: Mandatory use of prolonged immunosuppression in organ transplantation is complicated by ...
Increased risk of malignancy is a well-known complication of heart transplantation. In this report t...
Objectives: Mandatory use of prolonged immunosuppression in organ transplantation is complicated by ...
Background: Heart transplantation and malignancy connect in several ways. Cancer can be an incidenta...
BACKGROUND: Malignancy is a concern in cardiac transplant recipients, but the temporal trends of de ...
WOS: 000269540900029PubMed ID: 19486222Background: Malignancy is an important complication after hea...
This study sought to assess the incidence of neoplastic disease after transplantation in Chinese hea...
As the survival rate of cardiac recipients improves, higher incidence of malignancy in the late post...
Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by ...
Background. Malignancy is the leading cause of death in Taiwan. The risk of malignancy is higher in ...
To assess the long-term risk of developing cancer among heart transplant recipients compared to the ...
[Abstract] Neoplasm history increases morbidity and mortality after solid organ transplantation and ...
The risk of cancer in heart transplant recipients. Association between heart transplantation and the...
The prevalence of different cancers after heart transplant (HT) is unclear due to small and conflict...
BackgroundThe purpose of this study was to assess the incidence and type of malignancies after heart...
OBJECTIVES: Mandatory use of prolonged immunosuppression in organ transplantation is complicated by ...
Increased risk of malignancy is a well-known complication of heart transplantation. In this report t...
Objectives: Mandatory use of prolonged immunosuppression in organ transplantation is complicated by ...
Background: Heart transplantation and malignancy connect in several ways. Cancer can be an incidenta...
BACKGROUND: Malignancy is a concern in cardiac transplant recipients, but the temporal trends of de ...
WOS: 000269540900029PubMed ID: 19486222Background: Malignancy is an important complication after hea...
This study sought to assess the incidence of neoplastic disease after transplantation in Chinese hea...
As the survival rate of cardiac recipients improves, higher incidence of malignancy in the late post...
Prolonged or intensive immunosuppressive therapy used after organ transplantation is complicated by ...
Background. Malignancy is the leading cause of death in Taiwan. The risk of malignancy is higher in ...
To assess the long-term risk of developing cancer among heart transplant recipients compared to the ...